Targeting Notch signaling pathway in cancer: Clinical development advances and challenges

Naoko Takebe(National Institutes of Health), Dat Nguyen(National Institutes of Health), Sherry X. Yang(National Institutes of Health)
Pharmacology & Therapeutics
September 27, 2013
10.1016/j.pharmthera.2013.09.005
Cited by 403Open Access
Full Text

Abstract

Related Papers

A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain
Bart De Strooper, Wim Annaert, Philippe Cupers et al.|Nature|1999|2.1k
Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis
Irene Noguera‐Troise, Christopher Daly, Nicholas Papadopoulos et al.|Nature|2006|1k
Notch signalling in solid tumours: a little bit of everything but not all the time
Prathibha Ranganathan, Kelly Weaver, Anthony J. Capobianco|Nature reviews. Cancer|2011|812
The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching
Steven Suchting, Catarina Freitas, Ferdinand le Noble et al.|Proceedings of the National Academy of Sciences|2007|795
Nuclear signalling by tumour-associated antigen EpCAM
Dorothea Maetzel, Sabine Denzel, Brigitte Mack et al.|Nature Cell Biology|2009|726